GlobalRPh clinical medication-review education Beyond the Pill Count: How Whole-List Review Reveals Hidden Medication Burden How whole-list review can uncover cumulative effects, selected high-consequence combinations, reconciliation gaps, and discussion-ready deprescribing questions that single-drug checks may miss. This article explains the Version 1.5 GlobalRPh analyzer, its formulas,
Family Practice Medicine
Beyond LDL-C: Understanding Cardiovascular Risk With PREVENT, ApoB, Lp(a), Non-HDL-C and Advanced Lipid Analysis
GlobalRPh Clinical TechnologyBeyond LDL-C: Understanding Cardiovascular Risk With PREVENT, ApoB, Lp(a), Non-HDL-C and Advanced Lipid AnalysisIntroducing the GlobalRPh Cardiovascular Risk and Advanced Lipid Analyzer, a layered cardiovascular prevention tool that combines the standard lipid panel with advanced lipoprotein markers, derived calculations, kidney and metabolic context, coronary calcium, and the American
RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection
RSV Monoclonal Antibodies: A Paradigm Shift in Infant Protection Review Abstract Purpose: This review examines the evolving role of long-acting respiratory syncytial virus monoclonal antibodies in preventing RSV lower respiratory tract disease in infants and selected young children. Methodology: This article reviews current CDC and
Reducing Low-Value Testing in Family Medicine: High-Yield Diagnostic Stewardship for Common Outpatient Complaints
Reducing Low-Value Testing in Family Medicine: High-Yield Diagnostic Stewardship for Common Outpatient Complaints Review Abstract Low-value diagnostic testing is common in family medicine. These tests can expose patients to false-positive results, incidental findings, and unnecessary treatments. They may also involve radiation, lead to higher costs,
The Changing Geography of Sexually Transmitted Infections in the United States
The Changing Geography of Sexually Transmitted Infections in the United States: State-Level Burden, Emerging Threats, and the Limits of Single-Exposure Risk Prediction Emerging Risks Abstract Purpose: This paper reviews recent U.S. trends in sexually transmitted infections (STIs), commonly called sexually transmitted diseases (STDs) when clinical disease
The New Hospitalist Dilemma: When Every Elderly Admission Is a Delirium Prevention Case
The New Hospitalist Dilemma: When Every Elderly Admission Is a Delirium Prevention Case Review Abstract Delirium is one of the most common and consequential complications of hospitalization in older adults. It is associated with longer length of stay, functional decline, institutionalization, mortality, higher costs, and
The Cervical Screening Shake-Up: Primary HPV Testing, Genotyping, and Real-World Confusion
The Cervical Screening Shake-Up: Primary HPV Testing, Genotyping, and Real-World Confusion Review Abstract The transition from cytology-centered cervical cancer screening to primary high-risk human papillomavirus testing represents one of the most important changes in preventive gynecologic care. Primary HPV testing is more sensitive than cytology
Nail Disorders as Clues to Systemic Disease: Evidence, Limitations, and Diagnostic Value in Clinical Practice
Nail Disorders as Clues to Systemic Disease: Evidence, Limitations, and Diagnostic Value in Clinical Practice Review Abstract The physical examination remains a cornerstone of clinical medicine, yet certain components are frequently overlooked despite their diagnostic value. Among these, examination of the nail unit represents a
The Glucagon Paradox in Next-Generation Incretin Therapy: GLP-1, GIP, and Glucagon Receptor Co-Agonism
The Glucagon Paradox in Next-Generation Incretin Therapy: How GLP-1, GIP, and Glucagon Receptor Co-Agonism May Amplify Weight Loss Despite Glucagon’s Hyperglycemic Biology D. Mcauley Abstract The development of dual and triple incretin-based receptor agonists represents a major advance in the pharmacologic treatment of obesity, type
Obesity, Metabolic Syndrome, and ‘Difficult-to-Treat’ Psoriatic Arthritis: Is Inflammation Only Half the Story?
Obesity, Metabolic Syndrome, and ‘Difficult-to-Treat’ Psoriatic Arthritis Is Inflammation Only Half the Story Review Abstract Psoriatic arthritis (PsA) is a chronic, immune mediated inflammatory musculoskeletal disease that affects a substantial proportion of individuals with psoriasis. Characterized by peripheral arthritis, enthesitis, dactylitis, axial involvement, and progressive joint damage, PsA is associated
